Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Allogene Therapeutics (ALLO) has issued an announcement.
Allogene Therapeutics, Inc. has appointed Annie Yoshiyama as its new principal accounting officer, bringing with her extensive financial expertise from previous roles at AN2 Therapeutics, Tricida, and Dolby Laboratories. In parallel, the company’s 2024 Annual Meeting witnessed the election of four Class III Directors, approval of executive compensation, and ratification of Ernst & Young LLP as its independent auditor for the year, with significant shareholder participation and support for these agendas.
See more data about ALLO stock on TipRanks’ Stock Analysis page.
